Humana (HUM) is a publicly traded Healthcare sector company. As of October 3, 2026, HUM trades at $385.85 with a market cap of $45.59B and a P/E ratio of 36.02. HUM moved +2.29% today. Year to date, HUM is +46.84%; over the trailing twelve months it is +51.34%. Its 52-week range spans $163.11 to $428.88. Analyst consensus is buy with an average price target of $431.67. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for HUM, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $385.85 |
| Market Cap | $45.59B |
| P/E Ratio | 36.02 |
| EPS | $10.66 |
| Dividend Yield | 0.89% |
| 52-Week High | $428.88 |
| 52-Week Low | $163.11 |
| Volume | 587.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $145.68B |
| Net Income | $1.29B |
| Gross Margin | 0.00% |
23 analysts cover HUM: 0 strong buy, 12 buy, 10 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $431.67.